Insider Cluster (1 insider) ·Filed Mar 2, 2026

RMD

RESMED INC
NEUTRAL
Impact 4/10
Horizonimmediate Processed6mo ago
Insider cluster: 3 insiders, $2.0M total
Actionable Insight • Neutral

This activity is consistent with routine option monetization and pre-scheduled trading plans. No signal of negative sentiment; monitor for additional sales outside this cluster.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
RMD ▼ -19.05% at T+60d
NEUTRAL call ✗ call lost -19.05% · α vs SPY -28.38% · entry $256.94 → $207.98
Entry anchored
Feb 27, 03:59 PM ET
via exchange tick
T+1d
+0.32%
call +0.32% · α +1.23%
$257.75
settled 7mo ago
T+5d
-1.90%
call -1.90% · α -0.69%
$252.06
settled 7mo ago
T+20d
-14.38%
call -14.38% · α -6.44%
$220.00
settled 6mo ago
T+60d
-19.05%
call -19.05% · α -28.38%
$207.98
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

ResMed CEO Michael J. Farrell exercised stock options and sold 4,991 shares in the open market for approximately $1.25 million. The transaction was part of a pre-arranged trading plan and not an outright purchase, with no cash outlay for the exercised shares.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
1

Key Facts

  • CEO Michael J. Farrell exercised 9,982 derivative securities in total (two tranches of 4,991 shares), one at $0 and one at $146.34 per share.
  • Farrell sold 4,991 shares in the open market at $251.0322 per share, generating $1,252,901.71 in proceeds.
  • The exercise at $0 suggests a cashless exercise or option swap, common in pre-arranged plans.
  • Total open-market sale value: ~$1.25M, representing 0.0035% of ResMed’s $36.0B market cap — immaterial in scale.

Financial Impact

$1.25 million in open-market sales by CEO; no net buying, only exercise and partial sale

insider ownershipshare countinsider sentiment

Risk Factors

  • Perception risk if media mischaracterizes the sale as insider skepticism, though structure suggests planned execution.
  • Concentration risk in executive ownership if further monetization continues.

Market Snapshot

Exchange
OTC

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (3 trades, 7d window)cluster-RMD-1773232203311
11 reports for RMD
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +28.97%Jun 1, 2026
Filters
Rows
Reports for RMD — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
Insider Cluster
NEUTRAL ★ 4/10
$219.58 $228.42▲ +4.03%▲ +4.52%$218.89 (−0.31%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$224.84 $219.98▼ −2.16%▼ −1.76%$218.89 (−2.65%)
Jul 7, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$205.84 $193.01▼ −6.23%▼ −7.10%$218.89 (+6.34%)
Jun 1, 2026
17w ago
Press Release
BULLISH ★ 5/10
$182.75 $196.94▲ +7.77%▲ +10.73%$218.89 (+19.78%)
May 19, 2026
19w ago
Press Release
BEARISH ★ 5/10
$209.14 $203.22▲ +2.83%▲ +4.63%$218.89 (−4.66%)
Apr 1, 2026
26w ago
Press Release
NEUTRAL ★ 2/10
$224.09 $228.07▲ +1.78%▼ −1.84%$218.89 (−2.32%)
Apr 1, 2026
26w ago
Insider Cluster
NEUTRAL ★ 3/10
$222.19 $228.02▲ +2.62%▼ −1.14%$218.89 (−1.48%)
Apr 1, 2026
26w ago
Insider Cluster
BEARISH ★ 5/10
$222.19 $228.02▼ −2.62%▲ +1.14%$218.89 (+1.48%)
Mar 2, 2026
30w ago
Insider Cluster
NEUTRAL ★ 4/10
$256.94 $252.06▼ −1.90%▼ −0.69%$218.89 (−14.81%)
Mar 2, 2026
30w ago
Insider Cluster
NEUTRAL ★ 3/10
$256.94 $252.06▼ −1.90%▼ −0.69%$218.89 (−14.81%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 11, 2026